Azitra, Inc. (AZTR)
AZTR Stock Price Chart
Explore Azitra, Inc. interactive price chart. Choose custom timeframes to analyze AZTR price movements and trends.
AZTR Company Profile
Discover essential business fundamentals and corporate details for Azitra, Inc. (AZTR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
20 Jun 2023
Employees
12.00
Website
https://azitrainc.comCEO
Francisco D. Salva
Description
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
AZTR Financial Timeline
Browse a chronological timeline of Azitra, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.79.
Stock split effective on 21 Aug 2025
Shares were split 6.66 : 1 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 11 Aug 2025
EPS came in at -$1.20 surpassing the estimated -$1.40 by +14.29%.
Earnings released on 13 May 2025
EPS came in at -$1.53 .
Earnings released on 21 Mar 2025
EPS came in at -$0.63 falling short of the estimated -$0.51 by -23.53%, while revenue for the quarter reached $7.49M .
Earnings released on 12 Nov 2024
EPS came in at -$1.13 surpassing the estimated -$3.20 by +64.69%.
Earnings released on 12 Aug 2024
EPS came in at -$18.24 surpassing the estimated -$21.44 by +14.93%, while revenue for the quarter reached $7.50K .
Stock split effective on 1 Jul 2024
Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 May 2024
EPS came in at -$29.99 .
Earnings released on 29 Apr 2024
EPS came in at -$6.08 , while revenue for the quarter reached $90.00K .
Earnings released on 14 Nov 2023
EPS came in at -$31.99 , while revenue for the quarter reached $310.70K .
Earnings released on 14 Aug 2023
EPS came in at -$2.36 , while revenue for the quarter reached $172.00K .
Earnings released on 31 Mar 2023
EPS came in at -$6.10 , while revenue for the quarter reached $113.30K .
Earnings released on 31 Dec 2022
EPS came in at -$10.04 , while revenue for the quarter reached $30.50K .
Earnings released on 30 Sept 2022
EPS came in at -$6.00 , while revenue for the quarter reached $48.50K .
Earnings released on 30 Jun 2022
EPS came in at -$4.69 , while revenue for the quarter reached $85.00K .
Earnings released on 31 Mar 2022
EPS came in at -$5.77 , while revenue for the quarter reached $120.00K .
AZTR Stock Performance
Access detailed AZTR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.